
Korean pharma scrambles to catch up on ESG as global standards tighten
Environmental, social, and governance (ESG) values have moved from corporate buzzword to business necessity in Korea’s pharmaceutical industry. Global investors and regulators increasingly demand high ESG standards, and Korean drugmakers are playing catch- …